Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury
- PMID: 33004548
- DOI: 10.1136/gutjnl-2020-321565
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury
Abstract
Objective: Chronic alcohol consumption is an important cause of liver-related deaths. Specific intestinal microbiota profiles are associated with susceptibility or resistance to alcoholic liver disease in both mice and humans. We aimed to identify the mechanisms by which targeting intestinal microbiota can improve alcohol-induced liver lesions.
Design: We used human associated mice, a mouse model of alcoholic liver disease transplanted with the intestinal microbiota of alcoholic patients and used the prebiotic, pectin, to modulate the intestinal microbiota. Based on metabolomic analyses, we focused on microbiota tryptophan metabolites, which are ligands of the aryl hydrocarbon receptor (AhR). Involvement of the AhR pathway was assessed using both a pharmacological approach and AhR-deficient mice.
Results: Pectin treatment modified the microbiome and metabolome in human microbiota-associated alcohol-fed mice, leading to a specific faecal signature. High production of bacterial tryptophan metabolites was associated with an improvement of liver injury. The AhR agonist Ficz (6-formylindolo (3,2-b) carbazole) reduced liver lesions, similarly to prebiotic treatment. Conversely, inactivation of the ahr gene in alcohol-fed AhR knock-out mice abrogated the beneficial effects of the prebiotic. Importantly, patients with severe alcoholic hepatitis have low levels of bacterial tryptophan derivatives that are AhR agonists.
Conclusions: Improvement of alcoholic liver disease by targeting the intestinal microbiota involves the AhR pathway, which should be considered as a new therapeutic target.
Keywords: alcohol-induced injury; alcoholic liver disease; intestinal bacteria; mucus; prebiotic.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Disclosures: DC received travel funds from Biocodex and Gilead, lecture fees from Gilead, and royalties from John Libbey Eurotext. GK is a cofounder of everImmune. HS received unrestricted study grants from Danone, Biocodex, and Enterome and board membership, consultancy or lecture fees from Carenity, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Tillots, Enterome, Maat, BiomX, Biose, Novartis, and Takeda and is a cofounder of Exeliom Biosciences. GP received travel funds from Janssen and Gilead, consulting fees from Bayer, Biocodex, Roche, Gilead, Pierre Fabre, and Servier, and royalties from Elsevier-Masson, Solar, Flammation/Versilio, and John Libbey Eurotext. A-MC received travel funds and consulting fees from Biocodex and royalties from Elsevier-Masson, Solar, Flammation/Versilio and John Libbey Eurotext. All other authors declare no conflicts of interest.
Similar articles
-
Effect of diet and intestinal AhR expression on fecal microbiome and metabolomic profiles.Microb Cell Fact. 2020 Nov 30;19(1):219. doi: 10.1186/s12934-020-01463-5. Microb Cell Fact. 2020. PMID: 33256731 Free PMC article.
-
Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model.Front Immunol. 2019 Feb 4;10:91. doi: 10.3389/fimmu.2019.00091. eCollection 2019. Front Immunol. 2019. PMID: 30778350 Free PMC article.
-
Epigallocatechin-3-gallate mitigates cadmium-induced intestinal damage through modulation of the microbiota-tryptophan-aryl hydrocarbon receptor pathway.Ecotoxicol Environ Saf. 2024 Jul 15;280:116520. doi: 10.1016/j.ecoenv.2024.116520. Epub 2024 Jun 3. Ecotoxicol Environ Saf. 2024. PMID: 38833985
-
How Ah Receptor Ligand Specificity Became Important in Understanding Its Physiological Function.Int J Mol Sci. 2020 Dec 17;21(24):9614. doi: 10.3390/ijms21249614. Int J Mol Sci. 2020. PMID: 33348604 Free PMC article. Review.
-
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay.Gut Microbes. 2020 Nov 9;12(1):1859812. doi: 10.1080/19490976.2020.1859812. Epub 2020 Dec 17. Gut Microbes. 2020. PMID: 33382356 Free PMC article. Review.
Cited by
-
Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.Biomedicines. 2021 Dec 14;9(12):1912. doi: 10.3390/biomedicines9121912. Biomedicines. 2021. PMID: 34944732 Free PMC article. Review.
-
Interplay of Gut Microbes and Aryl Hydrocarbon Receptor in Alcohol-Associated Liver Disease.Cell Mol Gastroenterol Hepatol. 2022;13(1):343-345. doi: 10.1016/j.jcmgh.2021.10.001. Epub 2021 Oct 27. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34715085 Free PMC article. No abstract available.
-
Gut microbe-derived milnacipran enhances tolerance to gut ischemia/reperfusion injury.Cell Rep Med. 2023 Mar 21;4(3):100979. doi: 10.1016/j.xcrm.2023.100979. Cell Rep Med. 2023. PMID: 36948152 Free PMC article.
-
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role.Biomedicines. 2022 Feb 25;10(3):550. doi: 10.3390/biomedicines10030550. Biomedicines. 2022. PMID: 35327352 Free PMC article. Review.
-
Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways.Aging Dis. 2022 Jun 1;13(3):732-752. doi: 10.14336/AD.2021.1105. eCollection 2022 Jun. Aging Dis. 2022. PMID: 35656117 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources